Atlas Trials

Resistance Profile to Antiretroviral Medications in Individuals Living With HIV Who Failed a First-Line Regimen With Tenofovir / Lamivudina and Dolutegravir in Brasil

Clinical trial NCT07618507 · COMPLETED

Trial details

NCT number
NCT07618507
Sponsor
Federal University of São Paulo
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HIVHIV -1 Infection
Start date
2022-04-13
Primary completion
2024-03-08
Enrollment
777

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.